EPO and liver cancer: In early in vitro experiments, IL-1 and TNF-α were found to inhibit erythropoietin expression in isolated rat kidney and human liver cancer cells (39–41), but it has not been confirmed in humans whether inflammatory factors inhibit EPO production.